Collaborative problem-solving session where participants from companies developing in vivo CAR-T therapies share challenges and brainstorm solutions for T-cell targeting, biodistribution assessment, and potency measurement

• Discuss the toughest characterization challenges facing in vivo CAR-T developers today
• Benchmark analytical strategies for targeted delivery, potency, and product understanding
• Generate practical solutions through facilitated peer discussion and shared experiences